
间充质干细胞移植治疗免疫性疾病的研究进展
网络出版日期: 2013-03-07
基金资助
国家自然科学基金(81060324)
Research progress of transplantation of mesenchymal stem cells in treatment of immunological diseases
Online published: 2013-03-07
Supported by
National Natural Science Foundation of China, 81060324
龚飞翔, 汪 泱, 邓志锋 . 间充质干细胞移植治疗免疫性疾病的研究进展[J]. 上海交通大学学报(医学版), 2013 , 33(2) : 235 . DOI: 10.3969/j.issn.1674-8115.2013.02.022
Mesenchymal stem cells (MSCs), a subset of adult stem cells, possess multilineage differentiation potential and low immunogenicity. MSCs can promote angiogenesis, cell replacement therapy and neuroprotection. It has also been revealed that MSCs have immunomodulatory properties: inhibition of T cell proliferation, suppression of B cell proliferation and differentiation, modulation of natural killer cell activity and influencing dendritic cell maturation and function. Recent studies have demonstrated that transplantation of MSCs can effectively treat immunological diseases, such as graft-versus-host disease, rheumatoid arthritis, diabetes and multiple sclerosis. The research progress of transplantation of MSCs in treatment of immunological diseases is reviewed in this paper.
Key words: mesenchymal stem cell; immunomodulation; immunological disease
/
| 〈 |
|
〉 |